184 related articles for article (PubMed ID: 18473838)
21. Structural analysis of farnesyl pyrophosphate synthase from parasitic protozoa, a potential chemotherapeutic target.
Srivastava A; Mukherjee P; Desai PV; Avery MA; Tekwani BL
Infect Disord Drug Targets; 2008 Mar; 8(1):16-30. PubMed ID: 18473904
[TBL] [Abstract][Full Text] [Related]
22. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
Bacchi CJ; Yarlett N
Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
[TBL] [Abstract][Full Text] [Related]
23. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
McKerrow JH
Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
[TBL] [Abstract][Full Text] [Related]
24. [New drugs for the treatment of human parasitic protozoa].
Dupouy-Camet J
Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
[TBL] [Abstract][Full Text] [Related]
25. An introduction to the structural organization of parasitic protozoa.
de Souza W
Curr Pharm Des; 2008; 14(9):822-38. PubMed ID: 18473832
[TBL] [Abstract][Full Text] [Related]
26. Mannose-6-phosphate receptors for lysosomal enzymes cycle between the Golgi complex and endosomes.
Brown WJ; Goodhouse J; Farquhar MG
J Cell Biol; 1986 Oct; 103(4):1235-47. PubMed ID: 2945825
[TBL] [Abstract][Full Text] [Related]
27. [Target points of antiparasitic drugs].
Boczoń K
Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
[No Abstract] [Full Text] [Related]
28. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of coated vesicles bearing mannose 6-phosphate receptors for lysosomal enzymes in the Golgi region of I-cell fibroblasts.
Brown WJ; Farquhar MG
Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5135-9. PubMed ID: 6147848
[TBL] [Abstract][Full Text] [Related]
30. A dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane trafficking out of endosomal/lysosomal compartments: class E vps phenotype in mammalian cells.
Fujita H; Yamanaka M; Imamura K; Tanaka Y; Nara A; Yoshimori T; Yokota S; Himeno M
J Cell Sci; 2003 Jan; 116(Pt 2):401-14. PubMed ID: 12482925
[TBL] [Abstract][Full Text] [Related]
31. Reporter genes facilitating discovery of drugs targeting protozoan parasites.
Dube A; Gupta R; Singh N
Trends Parasitol; 2009 Sep; 25(9):432-9. PubMed ID: 19720564
[TBL] [Abstract][Full Text] [Related]
32. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
Ali V; Nozaki T
Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
[TBL] [Abstract][Full Text] [Related]
33. Endolyn-78, a membrane glycoprotein present in morphologically diverse components of the endosomal and lysosomal compartments: implications for lysosome biogenesis.
Croze E; Ivanov IE; Kreibich G; Adesnik M; Sabatini DD; Rosenfeld MG
J Cell Biol; 1989 May; 108(5):1597-613. PubMed ID: 2654137
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a recycling role for Rab7 in regulating a late step in endocytosis and in retention of lysosomal enzymes in Dictyostelium discoideum.
Buczynski G; Bush J; Zhang L; Rodriguez-Paris J; Cardelli J
Mol Biol Cell; 1997 Jul; 8(7):1343-60. PubMed ID: 9243512
[TBL] [Abstract][Full Text] [Related]
35. Novel amidines and analogues as promising agents against intracellular parasites: a systematic review.
Soeiro MN; Werbovetz K; Boykin DW; Wilson WD; Wang MZ; Hemphill A
Parasitology; 2013 Jul; 140(8):929-51. PubMed ID: 23561006
[TBL] [Abstract][Full Text] [Related]
36. Tubulin as an antiprotozoal drug target.
Werbovetz KA
Mini Rev Med Chem; 2002 Dec; 2(6):519-29. PubMed ID: 12370037
[TBL] [Abstract][Full Text] [Related]
37. Amphibian antimicrobial peptides and Protozoa: lessons from parasites.
Rivas L; Luque-Ortega JR; Andreu D
Biochim Biophys Acta; 2009 Aug; 1788(8):1570-81. PubMed ID: 19046939
[TBL] [Abstract][Full Text] [Related]
38. Two lysosomal membrane proteins, LGP85 and LGP107, are delivered to late endosomes/lysosomes through different intracellular routes after exiting from the trans-Golgi network.
Niwa K; Tanaka R; Murase H; Ishikawa T; Fujita H; Himeno M; Tanaka Y
Biochem Biophys Res Commun; 2003 Feb; 301(4):833-40. PubMed ID: 12589788
[TBL] [Abstract][Full Text] [Related]
39. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
Darkin-Rattray SJ; Gurnett AM; Myers RW; Dulski PM; Crumley TM; Allocco JJ; Cannova C; Meinke PT; Colletti SL; Bednarek MA; Singh SB; Goetz MA; Dombrowski AW; Polishook JD; Schmatz DM
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13143-7. PubMed ID: 8917558
[TBL] [Abstract][Full Text] [Related]
40. Lysosomal membrane protein composition, acidic pH and sterol content are regulated via a light-dependent pathway in metazoan cells.
Swetha MG; Sriram V; Krishnan KS; Oorschot VM; ten Brink C; Klumperman J; Mayor S
Traffic; 2011 Aug; 12(8):1037-55. PubMed ID: 21535339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]